Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial

Javier García-Campayo, Antoni Serrano-Blanco, Baltasar Rodero, Rosa Magallón, Marta Alda, Eva Andrés, Juan V Luciano, Yolanda López del Hoyo, Javier García-Campayo, Antoni Serrano-Blanco, Baltasar Rodero, Rosa Magallón, Marta Alda, Eva Andrés, Juan V Luciano, Yolanda López del Hoyo

Abstract

Background: Fibromyalgia is a prevalent and disabling disorder characterized by widespread pain and other symptoms such as insomnia, fatigue or depression. Catastrophization is considered a key clinical symptom in fibromyalgia; however, there are no studies on the pharmacological or psychological treatment of catastrophizing. The general aim of this study is to assess the effectiveness of cognitive-behaviour therapy and recommended pharmacological treatment for fibromyalgia (pregabalin, with duloxetine added where there is a comorbid depression), compared with usual treatment at primary care level.

Design: A multi-centre, randomized controlled trial involving three groups: the control group, consisting of usual treatment at primary care level, and two intervention groups, one consisting of cognitive-behaviour therapy, and the other consisting of the recommended pharmacological treatment for fibromyalgia.

Setting: 29 primary care health centres in the city of Zaragoza, Spain.

Sample: 180 patients, aged 18-65 years, able to understand and read Spanish, who fulfil criteria for primary fibromyalgia, with no previous psychological treatment, and no pharmacological treatment or their acceptance to discontinue it two weeks before the onset of the study.

Intervention: Psychological treatment is based on the manualized protocol developed by Prof. Escobar et al, from the University of New Jersey, for the treatment of somatoform disorders, which has been adapted by our group for the treatment of fibromyalgia. It includes 10 weekly sessions of cognitive-behaviour therapy. Pharmacological therapy consists of the recommended pharmacological treatment for fibromyalgia: pregabalin (300-600 mg/day), with duloxetine (60-120 mg/day) added where there is a comorbid depression).

Measurements: The following socio-demographic data will be collected: sex, age, marital status, education, occupation and social class. The diagnosis of psychiatric disorders will be made with the Structured Polyvalent Psychiatric Interview. Other instruments to be administered are the Pain Catastrophizing Scale, the Hamilton tests for Anxiety and for Depression, the Fibromyalgia Impact Questionnaire (FIQ), the EuroQuol-5 domains (EQ-5D), and the use of health and social services (CSRI). Assessments will be carried out at baseline, 1, 3, and 6 months. MAIN VARIABLE: Pain catastrophizing.

Analysis: The analysis will be per intent to treat. We will use the general linear models of the SPSS version 15 statistical package, to analyse the effect of the treatment on the result variable (pain catastrophizing).

Discussion: It is necessary to assess the effectiveness of pharmacological and psychological treatments for pain catastrophizing in fibromyalgia. This randomized clinical trial will determine whether both treatments are effective for this important prognostic variable in patients with fibromyalgia.

Trial registration: Current Controlled Trials ISRCTN10804772.

Figures

Figure 1
Figure 1
Flowchart: randomization, sampling and monitoring of patients.

References

    1. Chaves JE, Brown JM. Spontaneous cognitive strategies for the control of clinical pain and stress. Journal of Behavioural Medicine. 1987;10:263–276. doi: 10.1007/BF00846540.
    1. Jensen MP, Turner JA, Romano JM, Karoly P. Coping with chronic pain: A critical review of the literature. Pain. 1991;47:249–283. doi: 10.1016/0304-3959(91)90216-K.
    1. Keefe FJ, Brown GK, Wallston KA, Caldwell DS. Coping with rheumatoid arthritis: catastrophizing as a maladaptive strategy. Pain. 1989;37:51–6. doi: 10.1016/0304-3959(89)90152-8.
    1. Buenaver LF, Edwards RR, Haythornthwa JA. Pain-related catastrophizing and perceived social responses: Inter-relationships in the context of chronic pain. Pain. 2007;127:234–42. doi: 10.1016/j.pain.2006.08.018.
    1. McWilliams LA, Asmundson GJG. The relationship of adult attachment dimensions to pain-related fear, hypervigilance, and catastrophizing. Pain. 2007;127:27–34. doi: 10.1016/j.pain.2006.07.020.
    1. Sullivan MJL, Bishop S, Pivik J. The Pain Catastrophizing Scale: development and validation. Psychol Assess. 1995;7:524–32. doi: 10.1037/1040-3590.7.4.524.
    1. Keefe FJ, Lefebvre JC, Egert JR, Affleck G, Sullivan MJL, Caldwell DS. The relationship of gender to pain, pain behavior and disability in osteoarthritis patients: the role of catastrophizing. Pain. 2000;87:325–34. doi: 10.1016/S0304-3959(00)00296-7.
    1. Sullivan MJL, Tripp D, Santor D. Gender differences in pain and pain behavior: the role of catastrophizing. Cognitive Ther Res. 2000;24:121–34. doi: 10.1023/A:1005459110063.
    1. Picavet HS, Vlaeyen JW, Schouten JS. Pain catastrophizing and kinesiophobia: predictors of chronic low back pain. Am J Epidemiol. 2002;156:1028–34. doi: 10.1093/aje/kwf136.
    1. Jacobsen PB, Butler RW. Relation of cognitive coping and catastrophizing to acute pain and analgesic use following breast cancer surgery. J Behav Med. 1996;19:17–29. doi: 10.1007/BF01858172.
    1. Bedard GB, Reid GJ, McGrath PJ, Chambers CT. Coping and self-medication in a community sample of junior high school students. Pain Res Manag. 1997;2:151–6.
    1. Burton AK, Tillotson KM, Main CJ, Hollis S. Psychosocial predictors of outcome in acute and subchronic low back trouble. Spine. 1995;20:722–8. doi: 10.1097/00007632-199503150-00014.
    1. Sullivan MJL, Stanish W, Waite H, Sullivan ME, Tripp D. Catastrophizing, pain, and disability following soft tissue injuries. Pain. 1998;77:253–60. doi: 10.1016/S0304-3959(98)00097-9.
    1. Severeijns R, Vlaeyen JW, Hout MA Van den, Picavet HS. Pain catastrophizing is associated with health indices in musculoskeletal pain: a cross-sectional study in the Dutch community. Health Psychol. 2004;23:49–57. doi: 10.1037/0278-6133.23.1.49.
    1. Edwards RR, Smith MT, Kudel I, Haythornthwaite JA. Pain-related catastrophizing as a risk factor for suicidal ideation in chronic pain. Pain. 2006;126:272–79. doi: 10.1016/j.pain.2006.07.004.
    1. Buenaver LF, Edwards RR, Smith MT, Gramling SE, Haythornthwaite JA. Catastrophizing and pain-coping in young adults: associations with depressive symptoms and headache pain. J Pain. 2008;9:311–19. doi: 10.1016/j.jpain.2007.11.005.
    1. Edwards RR, Haythornthwaite JA, Sullivan MJ, Fillingim RB. Catastrophizing as a mediator of sex differences in pain: differential effects for daily pain versus laboratory-induced pain. Pain. 2004;111:335–41. doi: 10.1016/j.pain.2004.07.012.
    1. Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low back pain patients: Relationship to patient characteristics and current adjustment. Pain. 1983;17:33–44. doi: 10.1016/0304-3959(83)90125-2.
    1. Spanos NP, Radtke-Bodorik HL, Ferguson JD, Jones B. The effects of hypnotic susceptibility, suggestions for analgesia, and utilization of cognitive strategies on the reduction of pain. Journal of Abnormal Psychology. 1979;88:282–292. doi: 10.1037/0021-843X.88.3.282.
    1. Garcia Campayo J, Rodero B, Sobradiel N, Alda M, Montero J, Moreno S. Validation of the Spanish version of the Pain Catastrophizing Scale. Med Clin (Barc) 2008;131:487–93. doi: 10.1157/13127277.
    1. Wolfe F, Smythe HA, Yunus MB, Bennet RM, Bombardier C, Goldenberg DL. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160–72. doi: 10.1002/art.1780330203.
    1. Giesecke T, Williams DA, Harris RE, et al. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum. 2003;48:2916–2222. doi: 10.1002/art.11272.
    1. Nelson PJ, Tucker S. Developing an intervention to alter catastrophizing in persons with fibromyalgia. Orthop Nurs. 2006;25:205–14.
    1. García-Campayo J, Sanz Carrillo C. Gabapentin as treatment for somatization disorder patients: an open trial. J Clin Psychiatry. 2001;62:474.
    1. García-Campayo J, Sanz Carrillo C. The use of alternative medicines by somatoform disorder patients in Spain. Br J Gen Pract. 2000;50:487–88.
    1. Rodero B, Garcia Campayo J, Casasnuevas B, Sobradiel N. Exposition in imagination as treatment of catastrophizing in fibromyalgia: a pilot study. Actas Españolas Psiquiatr. 2008;36:223–26.
    1. Lawson K. Emerging pharmacological therapies for fibromyalgia. Curr Opin Invest Drugs. 2006;7:631–36.
    1. Armitage P, Berry G. Statistical Methods in Medical Research. 3. Oxford, Blackwell; 1994.
    1. Domingo-Salvany A, Regidor E, Alonso J, Alvarez-Dardet C. Una propuesta de medida de la clase social. Aten Primaria. 2000;25:350–63.
    1. Lobo A, Campos R, Pérez-Echeverría MJ, Izuzquiza J, García-Campayo J, Saz P, Marcos G. A new interview for the multiaxial assessment of psychiatric morbidity in medical settings. Psychological Medicine. 1993;23:505–510.
    1. Hamilton M. Rating depressive patients. J Clin Psychiatry. 1980;41:21–24.
    1. Ramos Brieva JA, Cordero-Villafafila A. A new validation of the Hamilton Rating Scale for Depression. J Psychiatr Res. 1988;22:21–8. doi: 10.1016/0022-3956(88)90024-6.
    1. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–55.
    1. Lobo A, Chamorro L, Luque A, Dal-Ré R, Badía X, Baró E. Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales. Med Clin (Barc) 2002;118:493–9.
    1. Burckhardt CS, Clark SR, Bennet RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol. 1991;18:728–733.
    1. Rivera J, Gonzalez T. The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol. 2004;22:554–60.
    1. Badia X, Roset M, Montserrat S, Herdman M, Segura A. The Spanish version of EuroQol: a description and its applications. European Quality of Life scale. Med Clin (Barc) 1999;112:79–85.
    1. Knapp M, (PSSRU and Centre for Economics of Mental Health, Institute of Psychiatry, University of Kent) Economic Evaluation of Mental Health Care. Ashgate Publishing Group; 1995.
    1. Oblikue consulting
    1. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. Third. New York: Oxford University Press; 2005.
    1. Dodd S, Bassi A, Bodger K, Williamson P. A comparison of multivariable regression models to analyse cost data. J Eval Clin Pract. 2006;12:76–86. doi: 10.1111/j.1365-2753.2006.00610.x.
    1. Austin PC, Ghali WA, Tu JV. A comparison of several regression models for analysing cost of CABG surgery. Stat Med. 2003;22:2799–815. doi: 10.1002/sim.1442.
    1. Efron B, Tibshirani RJ. An introduction to the bootstrap. 2. Boca Ratón, FL: Chapman and Hall/CRC; 1998.
    1. Garcia Campayo J, Magdalena J, Fernández E, Magallón R, Salas M, Sobradiel N. Effectiveness of treatments for fibromyalgia depending of level of care: a meta-analysis. Arthitis Res Ther. 2008;10:R81. doi: 10.1186/ar2455.
    1. Tang NK, Salkovskis PM, Poplavskaya E, Wright KJ, Hanna M, Hester J. Increased use of safety-seeking behaviours in chronic back pain patients with high health anxiety. Behav Res Ther. 2007;45:2821–35. doi: 10.1016/j.brat.2007.05.004.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa